As the Vice President for BioEnergy, Claus Fuglsang is leading Novozymes research in these areas and he oversees a portfolio of projects with more than 150 employees. As such, Claus has played a big part in the development of the first commercial cellulosic ethanol enzymes, Novozymes’ Cellic® CTec range as well as novel products in the existing grain based ethanol industry.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)